ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Vertex Pharmaceuticals, Inc.
(NQ:
VRTX
)
79.49
USD
+1.60 (+2.05%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Vertex Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
61
62
Next >
Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015
May 17, 2013
from
Business Wire News Releases
MDY, VRTX, KSU, AME: Large Inflows Detected at ETF
May 16, 2013
Symbols mentioned in this story: MDY, VRTX, KSU, AME Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
NASDAQ 100 Mid-day Update: Flat Top Performers: NFLX, NIHD, SIRI
May 15, 2013
New York, May 15th (TradersHuddle.com) - The NASDAQ 100 Index is flat trading at 0, which represents 0% versus its previous close. The index is mixed for the day with slightly more than 50% of its...
Read More
from
TradersHuddle.com
(MRK) Merck & Company Joins Forces With Bristol-Myers Squibb on Hepatitis C Virus Candidates
May 14, 2013
Merck & Co. Inc. (MRK) recently joined forces with Bristol-Myers Squibb (BMY) to conduct a... Visit StockBlogHub to view complete post.
Read More
category
Transcept Pharmaceuticals Inc
,
Cleveland BioLabs Inc
,
CBLI
, and 9 more.
from
Stock Blog Hub
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
Vertex Pharmaceuticals Crosses Above its 10-day MA (VRTX)
May 10, 2013
from
Comtex SmarTrend® News Briefs
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks...
Read More
category
Benzinga
,
ETFs
,
PJP
, and 22 more.
from
Latest Articles from Benzinga.com
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
May 09, 2013
from
Business Wire News Releases
Orphan Drug Companies Might Not Find A Parent
May 08, 2013
by Olga Oksman
Read More
category
NASDAQ:VRTX
,
EURONEXTPARIS:SNY
,
NASDAQ:NPSP
, and 2 more.
from
Forbes Real Time
MDY, VRTX, REGN, KSU: ETF Outflow Alert
May 08, 2013
Symbols mentioned in this story: MDY, VRTX, REGN, KSU Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
Many in U.S. don't get proper testing for hepatitis C- CDC
May 07, 2013
NEW YORK, May 7 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, U.S. health officials said on...
Read More
category
companyNews
from
Reuters: Company News
Midcaps Double S&P 500 Return: Get the Right ETF
May 07, 2013
category
O
,
REGN
,
GE
, and 10 more.
from
YCharts
NASDAQ Gainers Watch List: MannKind Corp. (NASDAQ:MNKD), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), and Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Added to Growing Stock Report's NASDAQ Gainers
May 07, 2013
New York, NY -- (SBWIRE) -- 05/07/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding MannKind Corp. (NASDAQ:MNKD), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), and...
Read More
from
SBWire - Latest Press Releases
NASDAQ 100 Round Up - Flat: BIDU, CTRP, VRTX
May 06, 2013
New York, May 6th (TradersHuddle.com) - The NASDAQ 100 Index is flat trading at 0, which represents 0% versus its previous close. The index is mixed for the day with slightly more than 50% of its...
Read More
from
TradersHuddle.com
Big Profits in Big Pharma
May 06, 2013
Don't let the less-than-stellar first quarter performances of a few well-known drug makers spook you: "Big Pharma" is a good investment over the long haul.
Read More
from
Update Content Feed for Financial Content
NASDAQ 100's Top Performers: GILD, ERTS, PCAR
May 03, 2013
New York, May 3rd (TradersHuddle.com) - The NASDAQ 100 Index is higher trading at 2949.52, which represents 1.32% versus its previous close. The index is mixed for the day with slightly more than 50%...
Read More
from
TradersHuddle.com
EPR adds FB, ARNA and VRTX to their Nasdaq Active Stock Watch List
May 03, 2013
from
ACCESSWIRE
Free Research Reports on AVEO, CXO, MWW and VRTX Issued by the Paragon Report
May 03, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
May 02, 2013
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential Source: George S. Mack of The Life Sciences Report (5/2/13) http://www.thelifesciencesreport.com/pub/na/15211 In January 2013, The...
Read More
category
GALE
,
NVS
,
ONXX
, and 17 more.
from
Bio-Wire.Com
Vertex (VRTX) VX-135 Looks Interesting, Thinks Deutsche Bank
May 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8299701 for the full story.
Read More
from
StreetInsider.com News Articles
NASDAQ Gainers Watch List: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Synacor, Inc. (NASDAQ:SYNC) Added to Growing Stock Report's NASDAQ Gainers Watch List.
May 01, 2013
New York, NY -- (SBWIRE) -- 05/01/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Synacor, Inc. (NASDAQ:SYNC).
Read More
from
SBWire - Latest Press Releases
AFFY, AMGN, VRTX, and QCOR Early Briefing and Review
May 01, 2013
from
ACCESSWIRE
Benzinga Market Primer: Wednesday, May 1
May 01, 2013
Futures Higher Ahead of Key Economic Data, Earnings U.S. equity futures rose in early pre-market trade ahead of key earnings and economic data. The FOMC rate decision and policy statement is due out...
Read More
category
Earnings
,
Benzinga
,
Global
, and 48 more.
from
Latest Articles from Benzinga.com
UPDATE 2-Vertex posts loss, raises cystic fibrosis sales view
April 30, 2013
April 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday increased by $20 million the 2013 forecast for sales of its cystic fibrosis drug that has become the focus for investors, and its shares rose...
Read More
category
companyNews
from
Reuters: Company News
Vertex posts quarterly loss as hepatitis C drug sales fall
April 30, 2013
April 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday reported a fourth successive quarterly loss as sales of its hepatitis C drug, Incivek, continued to plunge, but the biotechnology company...
Read More
category
companyNews
from
Reuters: Company News
Vertex Pharmaceuticals, Inc. (VRTX) Tops Q1 EPS by 21c
April 30, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8291050 for the full story.
Read More
from
StreetInsider.com News Articles
NASDAQ Decliners Watch List: Celgene Corporation (NASDAQ:CELG) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Added to Equity Profile Report's NASDAQ Decliners Watch List.
April 30, 2013
Wilmington, DE -- (SBWIRE) -- 04/30/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Celgene Corporation (NASDAQ:CELG) and Vertex Pharmaceuticals Incorporated...
Read More
from
SBWire - Latest Press Releases
Vertex Reports First Quarter 2013 Financial Results and Reviews Recent Progress in Development Programs for Cystic Fibrosis and Hepatitis C
April 30, 2013
from
Business Wire News Releases
Benzinga Market Primer: Tuesday, April 30
April 30, 2013
Futures Flat on Mixed Economic Data U.S. equity futures traded little changed in early pre-market trade following mixed global economic data. Mixed data out of Japan was followed by a flood of data out...
Read More
category
Earnings
,
Benzinga
,
Global
, and 53 more.
from
Latest Articles from Benzinga.com
Trading Radar for 04/30: Pfizer (PFE), Cummins (CMI), McGraw-Hill (MHP), DreamWorks (DWA), Sirius (SIRI) Report
April 29, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8286850 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
3
4
5
6
7
8
9
...
61
62
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
2
The Top 5 Spookiest Technologies
Nick Shchetko
3
The Tesla Model S Is the New Toyota Prius
Michael Comeau
4
Individual Investors and the Terrible, Horrible, No Good, Very Bad Day
Joe Digiammo
5
Black Swan Watch: Mexico's Super Volcano Could Be the Next Market Catalyst
Duncan Parker
See All Articles
»
Financial Product Guide